Knightscope Adds Elevated Body Temperature Detection to its Growing List of Features and Capabilities

Proximie Raises $38m Series B Funding To Accelerate Its Expansion in U.S. and European Markets

F-Prime Capital led financing, joined by Questa Capital, Eight Roads, and Maverick Ventures

RhoVac Reports to Mount Sinai Hospital in New York Join Phase IIb Study in Prostate Cancer

The participation of Mount Sinai was directly caused by the FDA approval of RhoVac's Fast Track Designation.

December 17, 2020

Knightscope, Inc., a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, announced today that it has added Elevated Body Temperature (EBT) detection to its growing list of features and capabilities.

In an effort to help combat the spread of COVID-19, Knightscope developed a way for its clients to measure body temperatures of employees and visitors entering a facility.

The Centers for Disease Control and Prevention indicates that a person with a temperature of 100.4 degrees or greater has a “fever,” a symptom of COVID-19.

Knightscope’s K1 Autonomous Security Robot (ASR) now has an optional EBT feature that monitors building entry points to identify high-risk individuals and further ensure safety in public spaces.

More here.

spot_img

DON'T MISS

Related Articles